INNOVATE BIOPHARMACEUTICLS I's ticker is and the CUSIP is 45782F955. A total of 2 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $8,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | +700.0% | 15,000 | +4900.0% | 0.00% | – |
| Q1 2019 | $1,000 | -92.9% | 300 | -95.2% | 0.00% | – |
| Q4 2018 | $14,000 | -91.8% | 6,200 | -75.3% | 0.00% | -100.0% |
| Q3 2018 | $171,000 | -37.4% | 25,100 | +116.4% | 0.00% | -50.0% |
| Q2 2018 | $273,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |